Ionis Pharmaceuticals IONS reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Ionis Pharmaceuticals beat estimated earnings by 9.68%, reporting an EPS of $-0.56 versus an estimate of $-0.62.
Revenue was up $8.00 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.44 which was followed by a 3.87% drop in the share price the next day.
Here's a look at Ionis Pharmaceuticals's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.71 | 0.28 | -0.51 | -0.58 |
EPS Actual | -0.27 | 1.55 | -0.34 | -0.26 |
Revenue Estimate | 125.21M | 259.15M | 158.38M | 129.94M |
Revenue Actual | 142.00M | 440.00M | 133.00M | 126.00M |
To track all earnings releases for Ionis Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.